Enorama Pharma AB (publ) (OM: ERMA)
Health Care · Pharmaceuticals · SE
Skr0.55
-12.42% today · -72.7% 1Y
Enorama Pharma AB (publ) (OM: ERMA) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $4.68M and employs 4 people.
Over the last twelve months the share price has lost 72.7%, trading between 0.21 and 3.00.
Tweenvest scores Enorama Pharma AB (publ) across four factors: quality 19/100, value 32/100, growth 0/100. Its strongest factor is value.
ERMA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.68M
- Revenue (TTM)
- $149.30K
- P/E
- —
- EPS
- -0.83
- Dividend yield
- —
- Beta (5Y)
- 1.83
- 52-week high
- Skr3.00
- 52-week low
- Skr0.21
- Avg volume (3M)
- —
- Shares outstanding
- 74.59M
- Employees
- 4
- Next earnings
- —
About Enorama Pharma AB (publ)
Enorama Pharma AB (publ), a pharmaceutical company, develops, manufactures, and sells medicated chewing gum in Sweden. It offers nicotine chewing gum and nicotine pouches under the NIC-S brand name. The company was incorporated in 2006 and is based in Malmö, Sweden.
- ISIN
- SE0008216329
- Founded
- 2006
- Listed since
- Jun 10, 2016
- Exchange
- OMX Nordic Exchange Stockholm
- Currency
- SEK
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Vasundhara Rasayans LimitedBSE: 538634 | $4.82M | Rs146.85 | +1.70% |
| Sweet Earth Holdings CorporationCNSX: SE | $4.79M | CA$— | — |
| Rua Bioscience LimitedNZSE: RUA | $4.76M | NZ$0.03 | -7.41% |
| Ananda Pharma PlcOTCPK: ANAN.F | $4.73M | $— | — |
| SPM CorporationHOSE: SPM | $4.57M | ₫8,600.00 | +1.18% |
| Acrux LimitedASX: ACR | $4.53M | AU$0.01 | +10.00% |
| Aanjaay Industries LimitedBSE: 524322 | $4.47M | Rs18.26 | -2.41% |
| Simply Solventless Concentrates Ltd.TSXV: HASH | $4.45M | CA$0.06 | -9.09% |
Figures last refreshed Oct 11, 2026.